• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Meritech Capital: Investment Portfolio & Startup News

Meritech Capital

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Inforcer lands £26m Series B led by Dawn Capital to equip MSPs with Microsoft security and AI toolsInforcer lands £26m Series B led by Dawn Capital to equip MSPs with Microsoft security and AI tools
    Inforcer
    22 Jul 2025

    Inforcer lands £26m Series B led by Dawn Capital to equip MSPs with Microsoft security and AI tools

    Inforcer enables MSPs to standardise, secure and manage Microsoft security and AI tools across multiple tenants, helping small and medium-sized businesses adopt enterprise-grade technology efficiently.

    Inforcer announces £15m Series A funding to bring Microsoft 365 standardisation to MSPsInforcer announces £15m Series A funding to bring Microsoft 365 standardisation to MSPs
    Inforcer
    16 Oct 2024

    Inforcer announces £15m Series A funding to bring Microsoft 365 standardisation to MSPs

    Inforcer offers a multi-tenant Microsoft 365 management platform for managed service providers, automating security policy deployment, compliance and reporting across customer environments at scale.

Meritech Capital
    • Cybersecurity
  • meritechcapital.com

More venture news

  • Subdial secures a £15m Series B led by Gresham House Ventures to buy and sell pre-owned watches
    Subdial
    16 Nov 2026

    Subdial secures a £15m Series B led by Gresham House Ventures to buy and sell pre-owned watches

    Series BConsumer
  • Griffin closes a £15m Series B led by Octagon Partners to add cards and stablecoin payments to its banking platform
    Griffin
    12 Nov 2026

    Griffin closes a £15m Series B led by Octagon Partners to add cards and stablecoin payments to its banking platform

    Series BFintech
  • T-Therapeutics closes a £100m Series B led by Advent Life Sciences and British Business Bank to take its cancer and autoimmune treatments into clinical trials
    T-Therapeutics
    5 Nov 2026

    T-Therapeutics closes a £100m Series B led by Advent Life Sciences and British Business Bank to take its cancer and autoimmune treatments into clinical trials

    Series BLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn